We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boehringer Ingelheim posted positive trial results for another Humira biosimilar, just a month after the FDA approved Amgen’s version, Amjevita. Read More
A year after the first approval of a treatment for female sexual desire disorders, the FDA has released draft guidance for drugmakers looking to develop the next female Viagra. Read More
The FDA and HHS have not responded to a senator’s demand to clarify their enforcement stance on state right-to-try laws that expand terminal patients’ access to unapproved drug therapies, more than 30 days after a hearing on the issue. Read More